158 related articles for article (PubMed ID: 24986201)
1. Medication adherence in schizophrenia: a comparison between outpatients and relapse cases.
Razali SM; Yusoff MZ
East Asian Arch Psychiatry; 2014 Jun; 24(2):68-74. PubMed ID: 24986201
[TBL] [Abstract][Full Text] [Related]
2. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
[TBL] [Abstract][Full Text] [Related]
3. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
[TBL] [Abstract][Full Text] [Related]
4. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
5. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
7. Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
Adelufosi AO; Adebowale TO; Abayomi O; Mosanya JT
Gen Hosp Psychiatry; 2012; 34(1):72-9. PubMed ID: 22036736
[TBL] [Abstract][Full Text] [Related]
8. Treatment adherence and quality of sleep in schizophrenia outpatients.
Afonso P; Brissos S; Cañas F; Bobes J; Bernardo-Fernandez I
Int J Psychiatry Clin Pract; 2014 Jan; 18(1):70-6. PubMed ID: 24047426
[TBL] [Abstract][Full Text] [Related]
9. Socio-demographic and clinical correlates of subjective quality of life among Nigerian outpatients with schizophrenia.
Adelufosi AO; Ogunwale A; Abayomi O; Mosanya JT
Psychiatry Res; 2013 Oct; 209(3):320-5. PubMed ID: 23452754
[TBL] [Abstract][Full Text] [Related]
10. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
11. Long- and short-term inpatients with schizophrenia in China: implications for community-based service development.
Wu G; Ouyang X; Yang B; Li L; Wang Z; Yi W; Liu C; Wang P; Chiu HF; Lee E; Xue Z; Rosenheck R; Liu Z
Asia Pac Psychiatry; 2013 Mar; 5(1):E39-46. PubMed ID: 23857794
[TBL] [Abstract][Full Text] [Related]
12. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
Jaeger S; Weißhaupt S; Flammer E; Steinert T
Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
[TBL] [Abstract][Full Text] [Related]
13. [Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].
El Ammouri A; Kisra H
Encephale; 2017 Dec; 43(6):522-527. PubMed ID: 27663045
[TBL] [Abstract][Full Text] [Related]
14. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
15. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study.
Novick D; Montgomery W; Treuer T; Aguado J; Kraemer S; Haro JM
BMC Psychiatry; 2015 Aug; 15():189. PubMed ID: 26239486
[TBL] [Abstract][Full Text] [Related]
16. Mediating role of illness representation among social support, therapeutic alliance, experience of medication side effects, and medication adherence in persons with schizophrenia.
Rungruangsiripan M; Sitthimongkol Y; Maneesriwongul W; Talley S; Vorapongsathorn T
Arch Psychiatr Nurs; 2011 Aug; 25(4):269-83. PubMed ID: 21784285
[TBL] [Abstract][Full Text] [Related]
17. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting hostility in outpatients with schizophrenia: 36-month results from the SOHO study.
Ochoa S; Suarez D; Novick D; Arranz B; Roca M; Baño V; Haro JM
J Nerv Ment Dis; 2013 Jun; 201(6):464-70. PubMed ID: 23686157
[TBL] [Abstract][Full Text] [Related]
19. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
Bressington D; Mui J; Gray R
Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
